High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris

Although the COVID‐19 pandemic peaked in March/April 2020 in France, the prevalence of infection is barely known. Using high‐throughput methods, we assessed herein the serological response against the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) of 1847 participants working in three...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Immunol
Hlavní autoři: Anna, François, Goyard, Sophie, Lalanne, Ana Ines, Nevo, Fabien, Gransagne, Marion, Souque, Philippe, Louis, Delphine, Gillon, Véronique, Turbiez, Isabelle, Bidard, François‐Clément, Gobillion, Aline, Savignoni, Alexia, Guillot‐Delost, Maude, Dejardin, François, Dufour, Evelyne, Petres, Stéphane, Richard‐Le Goff, Odile, Choucha, Zaineb, Helynck, Olivier, Janin, Yves L., Escriou, Nicolas, Charneau, Pierre, Perez, Franck, Rose, Thierry, Lantz, Olivier
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Immunity to infection
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753614/
https://ncbi.nlm.nih.gov/pubmed/33259646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/eji.202049058
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky